Tadalis® is a phosphodiesterase type 5 inhibitor. It is indicated for the treatment of benign prostatic hyperplasia and for the treatment of erectile dysfunction in adult men.
| DCI | TADALAFIL |
|---|---|
| Dosage | 20 mg |
| Trade name | TADALIS ® |
| Name of the originator | Cialis |
| Presentation | 02 tablets |
| Specialty | Urologie – Dysfonction érectile |
